Bizarre Patents
An enclosure for small animals which is wearable on the front or back of an animate being.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120129894 | Alkoxy Compounds for Disease Treatment The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these c... | 05/24/2012 |
| 20120108667 | HYDROXY CERAMIDES AND ANALOGS THEREOF AND THEIR USE FOR PREVENTING OR TREATING CANCER Disclosed herein are compounds, compositions, methods of treatment and synthetic methods for making compounds related to Ceramides and the use of Ceramides.... | 05/03/2012 |
| 20120108661 | EMULSIFIED COMPOSITION The emulsion composition of the present invention contains
| 05/03/2012 |
| 20120083533 | USE OF AMIDES OF MONO- AND DICARBOXYLIC ACIDS IN THE TREATMENT OF RENAL DISEASES A therapy for renal diseases, in particular renal diseases which develop in diabetic patients or patients who have been subjected to a treatment with an antitumor chemotherapy such as a platinum derivative and more generally cytotoxic drugs at renal level for treating o... | 04/05/2012 |
| 20120083532 | NOVEL USES The present invention relates to the use of a compound represented by the general formula (I), and pharmaceutically acceptable salts thereof, wherein: n is an integer from 2 to 5; p is an integer from 0 to 4; R1 is selected from the group consisting of a hydroxyl group,... | 04/05/2012 |
| 20120070473 | Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions A method for inhibiting formation of adhesions following abdominal surgery which involves application of an anti-static fatty acid ethoxylated amide (Cocamide DEA) in a matrix that is placed in the peritoneal cavity at the conclusion of an abdominal surgery and which re... | 03/22/2012 |
| 20120022165 | TRANSDERMAL COMPOSITIONS The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12 01/26/2012 | |
| 20120016032 | Cosmetic Composition Containing Calcium Citrate And N-Acylated Aminoalcohol Derivative To Prevent Dry Skin And Signs Of Cutaneous Ageing Cosmetic compositions comprising calcium citrate and at least one N-acylated aminoalcohol according to formula (I). Provided is a method of treating aged skin, comprising topically applying to the aged skin a... | 01/19/2012 |
| 20120009253 | PREPARATIONS FOR THE APPLICATION OF ANTI-INFLAMMATORY, ESPECIALLY ANTISEPTIC AGENTS AND/OR AGENTS PROMOTING THE HEALING OF WOUNDS OF THE LOWER RESPIRATORY TRACT Use of an anti-inflammatory agent such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the lower respiratory tract which are susceptible to the administration of such agents.... | 01/12/2012 |
| 20110306672 | CERAMIDE-ANALOGOUS METABOLITES This invention relates to certain ceramide-analogues of FTY720 (2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; fingolimod). In particular, the present invention relates to pharmaceutical compositions comprising these compounds, as well as processes for their prepar... | 12/15/2011 |
| 20110288037 | Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System The present invention relates to a pharmaceutical composition consisting of amides of mono- and di-carboxylic acids and hydroxystilbenes, and may be used for the treatment of pathologies caused, sustained and/or characterised by an abnormal general response of the immun... | 11/24/2011 |
| 20110263714 | Reverse Vesicle The reverse vesicle composition of the present invention includes (A) a sphingosine represented by formula (1) (wherein R1 represents a C4 to C30 linear alkyl group which may be substituted by a hydroxyl group, a carbonyl group, or an amino group; Y represent... | 10/27/2011 |
| 20110229540 | COSMETIC FORMULATIONS COMPRISING POROUS SILICON A cosmetic formulation comprising porous silicon is described.... | 09/22/2011 |
| 20110212173 | Controlled Release Treatment of Depression There is described a pharmaceutical composition for controlled release of an active compound wherein the active compound is selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, tri... | 09/01/2011 |
| 20110200669 | METHOD AND COMPOSITIONS OF CIVAMIDE TO TREAT DISEASE OF THE INTESTINES Compositions and a methods are described for treating disorders of the small and large bowel, such as Crohn's disease, ulcerative colitis and irritable bowel syndrome, without producing any treatment-related systemic side effects and with minimal or no abdominal discomf... | 08/18/2011 |
| 20110195018 | LOW MOLECULAR WEIGHT THYROID STIMULATING HORMONE RECEPTOR (TSHR) AGONISTS Disclosed are oxo-hydroquinazolines that are useful as selective TSHR agonists. The compounds may be used for detecting or treating thyroid cancer, or treating a bone degenerative disorder.... | 08/11/2011 |
| 20110190285 | METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT The present invention provides methods of treating a botulinum toxin related condition in a subject. In certain embodiments, the methods involve administering a compound of the following formulas: (I), (II), (III), (IV), (V). ... | 08/04/2011 |
| 20110182833 | Carboxamide Derivatives Having Cooling Properties Compounds of formula (I) wherein R1-R5, n and m have the same meaning as given in the description, having cooling properties are disclosed. Furthermore a process of their production and consumer pr... | 07/28/2011 |
| 20110171313 | COMPOSITION CONTAINING ULTRA-MICRONIZED PALMITOYL-ETHANOLAMIDE The present invention relates to a composition for pharmaceutical or veterinary use, comprising palmitoylethanolamide. In particular, the present invention relates to a pharmaceutical composition for human or veterinary use, containing a therapeutically efficient amount... | 07/14/2011 |
| 20110136668 | SYSTEM FOR PROTECTION OF PLANTS FROM PATHOGENS USING ALKAMIDES System, including methods compositions, and kits, for controlling the growth of fungi and other pathogens in plants using at least one alkamide, which may function by increasing or eliciting natural defense mechanisms of the plants against such pathogens.... | 06/09/2011 |
| 20110130448 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM The present invention relates to a compound of the formula:
| |
| 20110130456 | Hair Growth Regulating Agent A hair growth regulating agent containing, as an active ingredient, a compound represented by the following formula (I): [wherein R1 represents a substituted or unsubstituted, linear or branched C2 to C25 alkyl group; a group represented by the following formula (II): (... | 06/02/2011 |
| 20110118347 | TREATMENT Of RINGWORM A compound of the formula CH3(CH2)n—RA—(CH2)m-(CH═CH)q—(CH2)p—X wherein RA=(a); q=0 or 1; m and p are independently selected integers of at least 1; n=0 or an in... | 05/19/2011 |
| 20110086761 | COMPOSITIONS AND METHODS TO CONTROL OOMYCETE FUNGAL PATHOGENS The present invention relates to fungicidal compositions and their use for controlling oomycete pathogen induced disease or diseases in one or more plants.... | 04/14/2011 |
| 20110076321 | SELF-ADHESIVE POLYMER MATRIX CONTAINING SEA ALGAE EXTRACT A self-adhesive polymer matrix which comprises a polymer that forms a gel in water, water, a sea algae extract, and a monohydric or polyhydric alcohol.... | 03/31/2011 |
| 20110071100 | SULFOBETAINES FOR CANCER, OBESITY, MACULAR DEGENERATION, NEURODEGENERATIVE DISEASES The subject of the invention provides a pharmaceutical composition comprising a sulfobetaine, a sulfobetaine for therapy, uses thereof and methods of treating cancer obesity, age related macular degeneration or neurodegenerative diseases comprising administering a compo... | 03/24/2011 |
| 20110071118 | Methods of Making Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastointestinal Tract and Providing Enhanced Therapeuitc Activity A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible oil to which an phospholipid has been added to make a NSAID-containing fo... | 03/24/2011 |
| 20110065677 | Methods of Treating Inflammation with Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastrointestinal Tract and Providing Enhanced Therapeutic Activity A novel pharmaceutical composition is provided by which nonsteroidal anti-inflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such as lecithin oils or to a bio-compatible oil to which an phospholipid has been added to make a NSAID-containing fo... | 03/17/2011 |
| 20110065801 | ENZYMATIC SYNTHESIS OF SPHINGOLIPIDS The invention relates to the enzymatic synthesis of sphingolipids and compositions comprising sphingolipids from lysosphingolipids and carboxylic esters, and to cosmetic, dermatological or pharmaceutical formulations which comprise these sphingolipids or compositions.... | 03/17/2011 |
| 20110064681 | POLYURETHANES AS RHEOLOGICAL MODIFYING MEANS FOR COSMETIC PREPARATIONS The present invention relates to cosmetic preparations comprising novel polyurethanes or mixtures thereof as means for modifying rheological properties.... | 03/17/2011 |
| 20110059145 | TOPICAL COMPOSITION FOR EXTERNAL USE AND PROCESS FOR PRODUCING THE SAME A topical composition for external use comprising: a ceramide analogue-containing particle having a particle diameter of 0.001 μm to 0.2 μm; and a water-soluble polymer. It is preferable that, further, an oil component different from the ceramide analogue is contained... | 03/10/2011 |
| 20110046195 | Non-Lactone Carbocyclic and Heterocyclic Antagonists and Agonists of Bacterial Quorum Sensing Compounds which modulate quorum sensing in quorum sensing bacteria. Compounds of the invention inhibit quorum sensing and/or activate quorum sensing in various bacteria. Compounds that inhibit quorum sensing are particularly useful for inhibition of detrimental bacteria... | 02/24/2011 |
| 20110046225 | Pharmaceutical formulation containing palmitoyl ethanolamide and stearoyl ethanolamide The invention concerns new pharmaceutical formulations containing a blend of palmitoyl ethanolamide or PEA and stearoyl ethanolamide or SEA compounds as active principles. The formulation is suitable for oral, parenteral, topical, transdermic, rectal, sublingual, nasal,... | 02/24/2011 |
| 20110045073 | METHODS AND COMPOSITIONS OF SPHINGOLIPID FOR PREVENTING AND TREATING MICROBIAL INFECTIONS The present invention relates to controlled release composition for preventing and/or treating microbial infections in the oral cavity of a subject, said composition comprising a controlled delivery matrix which matrix has releasably associated therewith an amount of be... | 02/24/2011 |
| 20110034419 | Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease Disclosed are methods of diagnosing cardiovascular disease comprising measuring sphingolipids. Also disclosed are methods of predicting cardiovascular disease comprising measuring sphingolipids. Also disclosed are methods of identifying subjects at risk of developing ca... | 02/10/2011 |
| 20110034521 | COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES The present invention provides compounds and methods for treating zinc matrix metalloprotease dependent diseases. In certain embodiments, the compounds of the present invention have the following formulas: ... | 02/10/2011 |
| 20110020312 | METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS Methods and formulations for treating metabolic disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.... | 01/27/2011 |
| 20110021358 | USE OF SARMENTINE AND ITS ANALOGS FOR CONTROLLING PLANT PESTS Methods and compositions for controlling plant pests, particularly weeds and/or plant phytopathogens using sarmentine and/or analogs thereof are disclosed.... | 01/27/2011 |
| 20100322961 | Intranasal Drug Delivery System The present invention provides an intranasal drug delivery system containing capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homodihydrocapsaicin, and homocapsaicin in the form of oleoresin capsicum used as a carrier to quickly and effectively deliver a drug.... | 12/23/2010 |
| 20100305209 | Articles of Manufacture Releasing an Active Ingredient The present invention relates to articles of manufacture having a formulation distributed therein, wherein the formulation comprises an active agent which manifests a desirable property when released from the articles of manufacture. The present invention also relates t... | 12/02/2010 |
